• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Apellis Pharmaceuticals (APLS)

Common Shares
Sell: $18.05|Buy: $18.20|Change: 0.47 (2.69%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

Address

100 Fifth Avenue
Waltham
MA
USA
02451

Telephone

+1 617 9775700

Website

https://www.apellis.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Apellis Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 20252026-02-27T08:30:00
Apellis Pharmaceuticals Inc Fourth Quarter Earnings Results for 20252026-02-27T00:00:00
Apellis Pharmaceuticals Inc Annual Report for 20252026-02-27T00:00:00
Apellis Pharmaceuticals Inc Third Quarter Earnings Conference Call for 20252025-11-05T08:30:00
Apellis Pharmaceuticals Inc Third Quarter Earnings Results for 20252025-11-05T00:00:00
Apellis Pharmaceuticals Inc Second Quarter Earnings Conference Call for 20252025-08-01T08:30:00
Apellis Pharmaceuticals Inc Second Quarter Earnings Results for 20252025-08-01T00:00:00
Apellis Pharmaceuticals Inc Annual General Meeting for 20252025-06-05T10:00:00
Apellis Pharmaceuticals Inc First Quarter Earnings Conference Call for 20252025-05-07T08:30:00
Apellis Pharmaceuticals Inc First Quarter Earnings Results for 20252025-05-07T00:00:00

Previous key dates

NameKey Date
TD Cowen 45th Annual Health Care Conference2025-03-03T10:30:00
Apellis Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 20242025-02-28T08:30:00
Apellis Pharmaceuticals Inc Fourth Quarter Earnings Result for 20242025-02-28T00:00:00
Apellis Pharmaceuticals Inc Annual Report for 20242025-02-28T00:00:00
43rd Annual J.P. Morgan Healthcare Conference2025-01-13T09:45:00
Citi Global Healthcare Conference2024-12-05T13:00:00
Evercore ISI HealthCONx Conference2024-12-04T09:10:00
Jefferies London Healthcare Conference2024-11-19T08:30:00
Apellis Pharmaceuticals Inc Third Quarter Earnings Conference Call for 20242024-11-05T08:30:00
Apellis Pharmaceuticals Inc Third Quarter Earnings Results for 20242024-11-05T00:00:00
UBS Virtual Ophthalmology Day2024-10-02T08:30:00
Baird 2024 Global Healthcare Conference2024-09-11T09:05:00
Wells Fargo Annual Healthcare Conference 20242024-09-05T09:30:00
Apellis Pharmaceuticals VALIANT Top Line Phase III Results Conference Call2024-08-08T08:00:00
Apellis Pharmaceuticals Inc Second Quarter Earnings Conference Call for 20242024-08-01T08:30:00
Apellis Pharmaceuticals Inc Second Quarter Earnings Result for 20242024-08-01T00:00:00
Apellis Pharmaceuticals to Host a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare Conference2024-06-12T16:00:00
Apellis Pharmaceuticals Inc Annual General Meeting for 20242024-06-05T10:00:00
Bank of America Securities Healthcare Conference2024-05-14T08:00:00
Apellis Pharmaceuticals Inc First Quarter Earnings Conference Call for 20242024-05-07T08:30:00
Apellis Pharmaceuticals Inc First Quarter Earnings Result for 20242024-05-07T00:00:00
(ARVO) Annual Meeting2024-05-05T00:00:00
Apellis Pharmaceuticals to Host a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference 20242024-04-08T12:45:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.